Eranda (Ricinus communis)

Eranda (Ricinus communis) contains ricinoleic acid as its primary bioactive compound, which acts as an osmotic laxative by drawing water into the intestines. The castor oil derived from eranda seeds is FDA-approved for constipation relief and shows preliminary antibacterial properties.

Origin & History

Eranda (Ricinus communis), commonly known as castor bean plant, is a perennial flowering shrub native to Africa and cultivated globally in tropical regions for its seeds. Castor oil is extracted through cold-pressing or solvent extraction after purification to remove the toxic ricin, typically via fomentation in coconut water followed by washing and drying. The oil consists primarily of ricinoleic acid, a hydroxylated fatty acid comprising approximately 90% of its fatty acid content.

Historical & Cultural Context

In Ayurveda dating back to Charaka Samhita (~1500 BCE), Eranda is classified as behdniya (purgative) and vata-pacifying, traditionally used for constipation, rheumatism, arthritis, and in Panchakarma purification. Globally, various cultures have used seeds and oil as laxatives and antiparasitics, with African and South American folk systems employing it against parasites like Strongyloides and for conditions including amoebiasis and jaundice.

Health Benefits

• Constipation relief - FDA-approved as an osmotic laxative, though specific RCTs not identified in sources
• Joint pain and inflammation reduction - One case study reported symptomatic relief in rheumatoid arthritis patient, though lacked controls
• Antibacterial activity - In vitro studies showed ethanolic leaf extracts inhibited Mycobacterium tuberculosis at 200 μg/mL
• Traditional pain relief - Classified in Ayurveda as angmarda prashamana (body ache reliever), though clinical evidence limited
• Digestive support - Traditional use for abdominal disorders and as purgative in Panchakarma, evidence primarily observational

How It Works

Ricinoleic acid, comprising 85-90% of eranda's fatty acid content, binds to prostaglandin E receptors in the small intestine, stimulating adenylyl cyclase and increasing cyclic AMP levels. This triggers chloride and water secretion into the intestinal lumen while enhancing smooth muscle contractions. The anti-inflammatory effects may involve cyclooxygenase inhibition and reduced pro-inflammatory cytokine production.

Scientific Research

Limited high-quality clinical evidence exists, with most data from preclinical, traditional, or small case studies rather than large-scale RCTs or meta-analyses. One case study documented virechana (purgation therapy) with Eranda taila in a single rheumatoid arthritis patient showing symptomatic relief, though without controls or specified sample size. No specific PubMed PMIDs for RCTs were identified in the available sources.

Clinical Summary

Eranda is FDA-approved as an osmotic laxative based on established safety and efficacy data, though specific randomized controlled trials were not identified in available sources. One uncontrolled case study reported symptomatic improvement in a rheumatoid arthritis patient using eranda preparations. In vitro studies demonstrate antibacterial activity against various pathogens, but human clinical trials are lacking. The evidence base remains limited primarily to traditional use and preliminary laboratory research.

Nutritional Profile

Ricinus communis seed oil (castor oil) is composed primarily of fatty acids: ricinoleic acid (85–95% of total fatty acids), a hydroxylated monounsaturated omega-9 fatty acid that is the principal bioactive lipid responsible for laxative and anti-inflammatory effects. Minor fatty acids include linoleic acid (4–5%), oleic acid (2–4%), stearic acid (1–2%), and palmitic acid (0.5–1%). The seed kernel contains approximately 45–50% fixed oil by weight, 18–20% crude protein (including toxic lectin ricin and allergen CB-1A — these are largely removed during cold-pressing or heat processing of commercial castor oil), and 2–3% ash. Carbohydrate content is approximately 5–10% in whole seeds. Seeds contain the alkaloid ricinine (0.1–0.3% dry weight) and the phytotoxin ricin (up to 1–5% of seed protein), both of which are absent or negligible in pharmaceutical-grade castor oil after processing. Leaves contain flavonoids (rutin, quercetin glycosides at approximately 0.5–1.2 mg/g dry weight), tannins (2–5% dry weight), alkaloids (ricinine), and terpenoids. Roots and leaves contain kaempferol and its derivatives. Bioavailability note: Ricinoleic acid is hydrolyzed in the small intestine by lipases and acts locally on intestinal mucosa via EP3 prostaglandin receptors; systemic absorption is limited. Ricin, if present in unprocessed seed material, is highly toxic (estimated lethal dose ~1–10 μg/kg body weight) and is not present in processed castor oil at therapeutic concentrations. Mineral content of seeds includes calcium (~266 mg/100g), magnesium (~385 mg/100g), phosphorus (~670 mg/100g), and potassium (~~780 mg/100g), though seeds are not consumed directly due to toxicity concerns.

Preparation & Dosage

Traditional Ayurvedic dosing includes seed oil at 3-5 drops orally for laxative effects, and powder at 1-3 g after seed purification. For medicinal castor oil, 1-5 mL is suggested as the lowest effective amount. No standardized extracts with specific ricinoleic acid concentrations were detailed in clinical studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Triphala, Ginger, Turmeric, Ashwagandha, Guggulu

Safety & Interactions

Eranda oil can cause severe abdominal cramping, nausea, and diarrhea, particularly at higher doses. It may reduce absorption of fat-soluble vitamins (A, D, E, K) and interact with anticoagulant medications by affecting vitamin K status. Eranda is contraindicated during pregnancy as ricinoleic acid can stimulate uterine contractions and potentially cause miscarriage. Individuals with intestinal obstruction, appendicitis, or inflammatory bowel conditions should avoid use.